Filters

Latest News

2018-05-28 07:13:31

The R&D-based pharmaceutical industry supports the World Health Organization 5-year work plan and welcomes new era on health partnerships

28 May 2018, Geneva – IFPMA, the voice of the biopharmaceutical innovation and health progress around the world, made a ...

Read More

2018-05-25 10:56:58

IFPMA Welcomes Set-Up of New African Medicines Agency

Geneva, 25 May 2018 – To mark Africa Day, soon after African health ministers of ...

Read More

2018-05-24 10:34:13

International Alliance of Patients’ Organizations joins Fight the Fakes as 36th partner

Thursday, 24th May, Miami – Fight the Fakes is proud to announce that the International ...

Read More

2018-05-22 01:00:39

The pharmaceutical industry advocates for even greater collaboration as critical to future global health progress

Geneva, 22 May 2018 – IFPMA launches today “50 Years of Global Health Progress”. The ...

Read More

2018-01-24 16:23:21

The African Global Health Leaders Fellowship launched to support the future of health in Africa

The African Global Health Leaders Fellowship launched to support the future of health in Africa ...

Read More

2018-01-18 06:30:28

Report shows life sciences industry alliance is taking action to curb antimicrobial resistance, with more to come

The new AMR Industry Alliance of more than 100 biotech, diagnostics, generics and research-based biopharmaceutical ...

Read More

2017-12-15 08:00:20

Greg Perry Joins International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) as new Assistant Director General

Geneva, 15th December 2017 – IFPMA, the global research-based biopharmaceutical industry association, today announced the ...

Read More

Latest Statement

2018-05-25 13:23:33

IFPMA Statement: @WHA71 Item 12.7 – Pandemic Influenza Preparedness Framework for the sharing of influenza viruses and access to vaccines and other benefits

25 May 2018 Statement delivered by Paula Barbosa, IFPMA, Manager, Vaccines Policy   Mr Chairman, IFPMA and its member companies ...

Read More

2018-05-25 12:22:32

IFPMA Statement @WHA 71 agenda item 11.8 Preparation for a high-level meeting of the General Assembly on ending Tuberculosis

Geneva, 15th December 2017 – IFPMA, the global research-based biopharmaceutical ...

Read More

2018-05-24 15:44:48

IFPMA Statement @WHA 71 agenda item 11.7 Preparation for the third High-level Meeting of the General Assembly on the Prevention and Control of Non-communicable Diseases, to be held in 2018

Geneva, 15th December 2017 – IFPMA, the global research-based biopharmaceutical ...

Read More

2018-05-23 17:26:48

IFPMA Statement @WHA 71 agenda item 11.16 Global strategy and plan of action on public health, innovation and intellectual property

Geneva, 15th December 2017 – IFPMA, the global research-based biopharmaceutical ...

Read More

2018-05-23 17:19:39

IFPMA Statement @WHA 71 agenda item 11.5 Addressing the global shortage of, and access to, medicines and vaccines

Geneva, 15th December 2017 – IFPMA, the global research-based biopharmaceutical ...

Read More

2018-05-23 10:31:31

IFPMA Statement @WHA71 - Agenda item 11.1 Draft thirteenth general programme of work, 2019–2023

Geneva, 15th December 2017 – IFPMA, the global research-based biopharmaceutical ...

Read More

2018-03-23 00:00:47

IFPMA Statement: Biopharmaceutical industry marks World TB Day

Geneva, 15th December 2017 – IFPMA, the global research-based biopharmaceutical ...

Read More

mailto:s.kaenzig@ifpma.org +41 22 338 32 49
direct line
Twitter skaenzig

Sadia Kaenzig - Communications Manager

Sadia manages communications on issues including regulatory, intellectual property protection, trade and the economic footprint of the research-based pharmaceutical industry, research and development ecosystem and innovation, vaccines including influenza vaccines, and biotherapeutics.

mailto:m.depol@ifpma.org +41 22 338 32 20
direct line
Twitter @MorganePol

Morgane De Pol - Communications and Public Affairs

Morgane manages communications on issues including the research-based pharmaceutical industry’s commitment to achieving sustainable and inclusive development, advancing Universal Health Coverage, designing transformational partnerships to build healthier societies, boosting innovation for neglected tropical diseases, expanding access to high quality treatments for infectious and chronic diseases, fighting counterfeit medicines, and promoting resilient and efficient health systems.

A shared commitment to global health

Our Brouchure

2015 Edition

A shared commitment to global health

At IFPMA we advocate policies and practices that encourage the discovery of and access to life-saving and life-enhancing medicines and vaccines, for people everywhere.


Our Logo

Full colour EPS format

Our Logo

Full colour PNG format


FULL Name LOGO

Full colour EPS format


FULL Name LOGO

Full colour PNG format

Hot Topic

Pharmacovigilance: Do your bit, play your part!

Pharmacovigilance is one of the key steps to ensuring the safety of all our medicines, including biotherapeutics and vaccines. It encourages an ongoing cycle of communication between patients, health professionals, regulatory authorities, and our biopharma industry which is

Read More

Interview

IFPMA 2015 interview series 'Biodiversity, human health, and pharma'

A must-watch: Dr Manisha A. Desai, assistant general patent counsel at Eli Lilly and Company, gives her take on the importance of the Convention of Biodiversity and the Nagoya Protocol for the pharma industry. What's key is to

Read More

Our Blog

Latest Tweets

IFPMA members are working on increasing R&D for improved treatments and new vaccines to #stopTB. Read more here:… https://t.co/AjsjrEM8BR
  @IFPMA
RT @Ua_HealthSummit: Can the pharma industry be compared to other businesses? Do they have a "greater" call? Competing for the same investo…
2
  @IFPMA
A future without effective antibiotics? A scenario that is imperative to be avoided. Antibiotic stewardship is a cr… https://t.co/hRMA3ZyLOd
1
  @IFPMA
Our DG @ThomasCueni will be speaking about pricing and access to #cancer diagnostics and treatments at today’s… https://t.co/4XEpqSEB2F
3 1
  @IFPMA
Congratulations on this #GlobalHealthProgress! Find out more about industry’s efforts to eliminate #Trachoma, for e… https://t.co/RrzQTwrHN7
  @IFPMA